Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 89.390
Filter
Add filters

Document Type
Year range
1.
Ann Intern Med ; 174(9): 1325-1326, 2021 09.
Article in English | MEDLINE | ID: covidwho-1526997
2.
Ann Intern Med ; 174(9): 1344-1345, 2021 09.
Article in English | MEDLINE | ID: covidwho-1526993

Subject(s)
COVID-19 , SARS-CoV-2 , Humans
3.
Ann Intern Med ; 174(7): 1037, 2021 07.
Article in English | MEDLINE | ID: covidwho-1526991

Subject(s)
COVID-19 , SARS-CoV-2 , Humans
4.
Ann Intern Med ; 174(4): 579-580, 2021 04.
Article in English | MEDLINE | ID: covidwho-1526990

Subject(s)
COVID-19 , Masks , Humans , SARS-CoV-2 , Textiles
5.
Ann Intern Med ; 174(4): 579, 2021 04.
Article in English | MEDLINE | ID: covidwho-1526989

Subject(s)
COVID-19 , Masks , Humans , SARS-CoV-2 , Textiles
6.
Ann Intern Med ; 174(6): 887-888, 2021 06.
Article in English | MEDLINE | ID: covidwho-1526988
8.
Ann Intern Med ; 174(5): 734-735, 2021 05.
Article in English | MEDLINE | ID: covidwho-1526986
9.
Ann Intern Med ; 174(5): 734, 2021 05.
Article in English | MEDLINE | ID: covidwho-1526985
13.
Ann Intern Med ; 174(2): 287-288, 2021 02.
Article in English | MEDLINE | ID: covidwho-1526981
14.
Ann Intern Med ; 174(1): JC2, 2021 01.
Article in English | MEDLINE | ID: covidwho-1526979

ABSTRACT

SOURCE CITATION: Lamontagne F, Agoritsas T, Macdonald H, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379. 32887691.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , COVID-19/drug therapy , Coronavirus Infections/drug therapy , Pneumonia, Viral/drug therapy , Practice Guidelines as Topic , Betacoronavirus , Critical Illness , Humans , Pandemics , SARS-CoV-2 , World Health Organization
15.
16.
Clin J Am Soc Nephrol ; 16(11): 1755-1765, 2021 11.
Article in English | MEDLINE | ID: covidwho-1526737

ABSTRACT

Despite evidence of multiorgan tropism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with coronavirus disease 2019 (COVID-19), direct viral kidney invasion has been difficult to demonstrate. The question of whether SARS-CoV2 can directly infect the kidney is relevant to the understanding of pathogenesis of AKI and collapsing glomerulopathy in patients with COVID-19. Methodologies to document SARS-CoV-2 infection that have been used include immunohistochemistry, immunofluorescence, RT-PCR, in situ hybridization, and electron microscopy. In our review of studies to date, we found that SARS-CoV-2 in the kidneys of patients with COVID-19 was detected in 18 of 94 (19%) by immunohistochemistry, 71 of 144 (49%) by RT-PCR, and 11 of 84 (13%) by in situ hybridization. In a smaller number of patients with COVID-19 examined by immunofluorescence, SARS-CoV-2 was detected in 10 of 13 (77%). In total, in kidneys from 102 of 235 patients (43%), the presence of SARS-CoV-2 was suggested by at least one of the methods used. Despite these positive findings, caution is needed because many other studies have been negative for SARS-CoV-2 and it should be noted that when detected, it was only in kidneys obtained at autopsy. There is a clear need for studies from kidney biopsies, including those performed at early stages of the COVID-19-associated kidney disease. Development of tests to detect kidney viral infection in urine samples would be more practical as a noninvasive way to evaluate SARS-CoV-2 infection during the evolution of COVID-19-associated kidney disease.


Subject(s)
COVID-19/virology , Kidney Diseases/virology , Kidney/virology , SARS-CoV-2/pathogenicity , Animals , Biopsy , COVID-19/complications , COVID-19/diagnosis , COVID-19/mortality , COVID-19 Testing , Host-Pathogen Interactions , Humans , Kidney Diseases/diagnosis , Kidney Diseases/mortality , Predictive Value of Tests , Prognosis , Risk Assessment , Risk Factors
17.
J Med Case Rep ; 15(1): 558, 2021 Nov 15.
Article in English | MEDLINE | ID: covidwho-1526658

ABSTRACT

BACKGROUND: The new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) owing to its similarity to the previous severe acute respiratory syndrome (SARS), is characterized by causing, in most patients, nonspecific symptoms similar to those of the common flu. It has been reported that many coronavirus disease 2019 (COVID-19) patients presented neurological symptoms that involve the central and peripheral nervous systems. In addition, there have been several reports of patients who presented Guillain-Barré syndrome related to  COVID-19 , with sensory and motor compromise in the extremities. CASE PRESENTATION: In this report, we describe a rare case of Guillain-Barré syndrome in a 50-year-old Hispanic male with bilateral facial palsy as the only neurological manifestation, following SARS-CoV-2 infection. A complete neurophysiological study showed severe axonal neuropathy of the right and left facial nerves. CONCLUSION: Regardless of severity, clinicians must to be aware of any neurological manifestation generated by COVID-19 and start performing more neurophysiological tests to determine if the infection induces an axonal, myelin, or mixed involvement of the peripheral nervous system.


Subject(s)
COVID-19 , Guillain-Barre Syndrome , Facial Nerve , Guillain-Barre Syndrome/complications , Guillain-Barre Syndrome/diagnosis , Hispanic Americans , Humans , Male , Middle Aged , SARS-CoV-2
18.
Am J Physiol Lung Cell Mol Physiol ; 321(5): L958-L959, 2021 11 01.
Article in English | MEDLINE | ID: covidwho-1526552

Subject(s)
COVID-19 , China , Humans , SARS-CoV-2
19.
Ann Noninvasive Electrocardiol ; 26(3): e12852, 2021 05.
Article in English | MEDLINE | ID: covidwho-1526344
SELECTION OF CITATIONS
SEARCH DETAIL
...